None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Minimum age 65, maximum age 78 (1) Elderly individuals aged 65 and older who are able to participate in regular exercise (2) Individuals who voluntarily consent to participate in the study (3) Individuals with metabolic syndrome (Group 2)
Exclusion criteria
Exclusion criteria: (1) Individuals who have been diagnosed with a musculoskeletal disorder within the past six months and are unable to participate in walking or exercise programs, (2) Individuals with severe cardiovascular disease who are unable to participate in resistance exercise programs, (3) Individuals who are unable to perform daily activities independently due to depression, anxiety, insomnia, etc., (4) Individuals currently taking blood glucose-lowering medications, (5) Individuals who are currently losing weight or planning to lose weight, or who are already participating in a planned exercise program at least twice a week, (6) Individuals who are deemed unsuitable for participation in this clinical trial by the researcher or attending physician due to other factors that may affect the results of this clinical trial. However, if individuals are taking blood pressure medication or lipid-lowering medication (for hyperlipidemia), participation is permitted if the medication schedule remains consistent throughout the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body compositon(Height, Muscle mass, Fat mass, Fat percent);Neurokines;Physical fitness ;Metabolic syndrome indicators(ATP3);FGF-21;Adipokines | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive function test | — |
Countries
Korea, Republic of
Contacts
Kangwon National University